LEMAITRE VASCULAR, INC. Cost of Goods Sold (Deprecated 2018-01-31)
LEMAITRE VASCULAR, INC. (LMAT) reported Cost of Goods Sold (Deprecated 2018-01-31) of $7.52 million for the 3-month period ending 2018-03-31, per its 10-Q filed 2018-05-04.
Discontinued › Expense Statement
us-gaap:CostOfGoodsSold · last filed 2018-05-04
- LEMAITRE VASCULAR, INC. cost of goods sold (deprecated 2018-01-31) for the quarter ending 2018-03-31 was $7.52M, a 10.82% increase year-over-year.
- LEMAITRE VASCULAR, INC. cost of goods sold (deprecated 2018-01-31) for the quarter ending 2017-12-31 was $7.90M, a 11.38% increase year-over-year.
- LEMAITRE VASCULAR, INC. cost of goods sold (deprecated 2018-01-31) for the quarter ending 2017-09-30 was $7.25M, a 16.91% increase year-over-year.
- LEMAITRE VASCULAR, INC. cost of goods sold (deprecated 2018-01-31) for the quarter ending 2017-06-30 was $8.24M, a 17.30% increase year-over-year.
- LEMAITRE VASCULAR, INC. cost of goods sold (deprecated 2018-01-31) for fiscal 2017 was $30.17M, a 15.09% increase from fiscal 2016.
- LEMAITRE VASCULAR, INC. cost of goods sold (deprecated 2018-01-31) for fiscal 2016 was $26.21M, a 8.39% increase from fiscal 2015.
- LEMAITRE VASCULAR, INC. cost of goods sold (deprecated 2018-01-31) for fiscal 2015 was $24.19M, a 6.71% increase from fiscal 2014.
- LEMAITRE VASCULAR, INC. cost of goods sold (deprecated 2018-01-31) for fiscal 2014 was $22.67M, a 16.63% increase from fiscal 2013.
| Period end | Cost of Goods Sold (Deprecated 2018-01-31) 3 month | Cost of Goods Sold (Deprecated 2018-01-31) 6 month | Cost of Goods Sold (Deprecated 2018-01-31) 9 month | Cost of Goods Sold (Deprecated 2018-01-31) 12 month |
|---|---|---|---|---|
| 2018-03-31 | $7.52M 10-Q · filed 2018-05-04 | $15.42M derived: sum of 2 quarters · filed 2018-05-04 | $22.67M derived: sum of 3 quarters · filed 2018-05-04 | $30.90M derived: sum of 4 quarters · filed 2018-05-04 |
| 2017-12-31 | $7.90M derived: 10-K 12 month − 10-Q 9 month · filed 2018-03-09 | $15.15M derived: sum of 2 quarters · filed 2018-03-09 | $23.38M derived: sum of 3 quarters · filed 2018-03-09 | $30.17M 10-K · filed 2018-03-09 |
| 2017-09-30 | $7.25M 10-Q · filed 2017-11-03 | $15.48M derived: sum of 2 quarters · filed 2017-11-03 | $22.27M 10-Q · filed 2017-11-03 | $29.36M derived: sum of 4 quarters · filed 2018-05-04 |
| 2017-06-30 | $8.24M 10-Q · filed 2017-08-03 | $15.02M 10-Q · filed 2017-08-03 | $22.12M derived: sum of 3 quarters · filed 2018-05-04 | $28.31M derived: sum of 4 quarters · filed 2018-05-04 |
| 2017-03-31 | $6.79M 10-Q · filed 2018-05-04 | $13.88M derived: sum of 2 quarters · filed 2018-05-04 | $20.08M derived: sum of 3 quarters · filed 2018-05-04 | $27.10M derived: sum of 4 quarters · filed 2018-05-04 |
| 2016-12-31 | $7.09M derived: 10-K 12 month − 10-Q 9 month · filed 2018-03-09 | $13.29M derived: sum of 2 quarters · filed 2018-03-09 | $20.31M derived: sum of 3 quarters · filed 2018-03-09 | $26.21M 10-K · filed 2018-03-09 |
| 2016-09-30 | $6.20M 10-Q · filed 2017-11-03 | $13.22M derived: sum of 2 quarters · filed 2017-11-03 | $19.12M 10-Q · filed 2017-11-03 | $25.20M derived: sum of 4 quarters · filed 2018-03-09 |
| 2016-06-30 | $7.02M 10-Q · filed 2017-08-03 | $12.92M 10-Q · filed 2017-08-03 | $19.00M derived: sum of 3 quarters · filed 2018-03-09 | $24.51M derived: sum of 4 quarters · filed 2018-03-09 |
| 2016-03-31 | $5.90M 10-Q · filed 2017-05-04 | $11.98M derived: sum of 2 quarters · filed 2018-03-09 | $17.49M derived: sum of 3 quarters · filed 2018-03-09 | $24.26M derived: sum of 4 quarters · filed 2018-03-09 |
| 2015-12-31 | $6.08M derived: 10-K 12 month − 10-Q 9 month · filed 2018-03-09 | $11.59M derived: sum of 2 quarters · filed 2018-03-09 | $18.36M derived: sum of 3 quarters · filed 2018-03-09 | $24.19M 10-K · filed 2018-03-09 |
| 2015-09-30 | $5.51M 10-Q · filed 2016-11-04 | $12.28M derived: sum of 2 quarters · filed 2016-11-04 | $18.11M 10-Q · filed 2016-11-04 | $23.96M derived: sum of 4 quarters · filed 2017-03-09 |
| 2015-06-30 | $6.77M 10-Q · filed 2016-08-05 | $12.60M 10-Q · filed 2016-08-05 | $18.45M derived: sum of 3 quarters · filed 2017-03-09 | $23.95M derived: sum of 4 quarters · filed 2017-03-09 |
| 2015-03-31 | $5.83M 10-Q · filed 2016-05-06 | $11.68M derived: sum of 2 quarters · filed 2017-03-09 | $17.18M derived: sum of 3 quarters · filed 2017-03-09 | $22.97M derived: sum of 4 quarters · filed 2017-03-09 |
| 2014-12-31 | $5.85M derived: 10-K 12 month − 10-Q 9 month · filed 2017-03-09 | $11.35M derived: sum of 2 quarters · filed 2017-03-09 | $17.14M derived: sum of 3 quarters · filed 2017-03-09 | $22.67M 10-K · filed 2017-03-09 |
| 2014-09-30 | $5.50M 10-Q · filed 2015-11-06 | $11.28M derived: sum of 2 quarters · filed 2015-11-06 | $16.81M 10-Q · filed 2015-11-06 | $22.77M derived: sum of 4 quarters · filed 2016-03-10 |
| 2014-06-30 | $5.79M 10-Q · filed 2015-08-06 | $11.31M 10-Q · filed 2015-08-06 | $17.27M derived: sum of 3 quarters · filed 2016-03-10 | $21.86M derived: sum of 4 quarters · filed 2016-03-10 |
| 2014-03-31 | $5.53M 10-Q · filed 2015-05-07 | $11.49M derived: sum of 2 quarters · filed 2016-03-10 | $16.07M derived: sum of 3 quarters · filed 2016-03-10 | $20.79M derived: sum of 4 quarters · filed 2016-03-10 |
| 2013-12-31 | $5.96M derived: 10-K 12 month − 10-Q 9 month · filed 2016-03-10 | $10.54M derived: sum of 2 quarters · filed 2016-03-10 | $15.26M derived: sum of 3 quarters · filed 2016-03-10 | $19.43M 10-K · filed 2016-03-10 |
| 2013-09-30 | $4.58M 10-Q · filed 2014-11-06 | $9.30M derived: sum of 2 quarters · filed 2014-11-06 | $13.47M 10-Q · filed 2014-11-06 | $17.84M derived: sum of 4 quarters · filed 2015-03-18 |
| 2013-06-30 | $4.71M 10-Q · filed 2014-08-07 | $8.89M 10-Q · filed 2014-08-07 | $13.25M derived: sum of 3 quarters · filed 2015-03-18 | $16.88M derived: sum of 4 quarters · filed 2015-03-18 |
| 2013-03-31 | $4.18M 10-Q · filed 2014-05-08 | $8.54M derived: sum of 2 quarters · filed 2015-03-18 | $12.17M derived: sum of 3 quarters · filed 2015-03-18 | $15.98M derived: sum of 4 quarters · filed 2015-03-18 |
| 2012-12-31 | $4.36M derived: 10-K 12 month − 10-Q 9 month · filed 2015-03-18 | $7.99M derived: sum of 2 quarters · filed 2015-03-18 | $11.81M derived: sum of 3 quarters · filed 2015-03-18 | $15.87M 10-K · filed 2015-03-18 |
| 2012-09-30 | $3.63M 10-Q · filed 2013-11-07 | $7.45M derived: sum of 2 quarters · filed 2013-11-07 | $11.50M 10-Q · filed 2013-11-07 | $15.39M derived: sum of 4 quarters · filed 2014-03-21 |
| 2012-06-30 | $3.82M 10-Q · filed 2013-08-09 | $7.87M 10-Q · filed 2013-08-09 | $11.76M derived: sum of 3 quarters · filed 2014-03-21 | $16.14M derived: sum of 4 quarters · filed 2014-03-21 |
| 2012-03-31 | $4.06M 10-Q · filed 2013-05-08 | $7.95M derived: sum of 2 quarters · filed 2014-03-21 | $12.33M derived: sum of 3 quarters · filed 2014-03-21 | $17.07M derived: sum of 4 quarters · filed 2014-03-21 |
| 2011-12-31 | $3.89M derived: 10-K 12 month − 10-Q 9 month · filed 2014-03-21 | $8.27M derived: sum of 2 quarters · filed 2014-03-21 | $13.01M derived: sum of 3 quarters · filed 2014-03-21 | $17.46M 10-K · filed 2014-03-21 |
| 2011-09-30 | $4.38M 10-Q · filed 2012-11-09 | $9.12M derived: sum of 2 quarters · filed 2012-11-09 | $13.57M 10-Q · filed 2012-11-09 | $17.65M derived: sum of 4 quarters · filed 2013-03-27 |
| 2011-06-30 | $4.74M 10-Q · filed 2012-08-10 | $9.19M 10-Q · filed 2012-08-10 | $13.27M derived: sum of 3 quarters · filed 2013-03-27 | $16.53M derived: sum of 4 quarters · filed 2013-03-27 |
| 2011-03-31 | $4.45M 10-Q · filed 2012-05-03 | $8.53M derived: sum of 2 quarters · filed 2013-03-27 | $11.79M derived: sum of 3 quarters · filed 2013-03-27 | $15.29M derived: sum of 4 quarters · filed 2013-03-27 |
| 2010-12-31 | $4.08M derived: 10-K 12 month − 10-Q 9 month · filed 2013-03-27 | $7.34M derived: sum of 2 quarters · filed 2013-03-27 | $10.84M derived: sum of 3 quarters · filed 2013-03-27 | $14.34M 10-K · filed 2013-03-27 |
| 2010-09-30 | $3.26M 10-Q · filed 2011-11-14 | $6.76M derived: sum of 2 quarters · filed 2011-11-14 | $10.26M 10-Q · filed 2011-11-14 | |
| 2010-06-30 | $3.50M 10-Q · filed 2011-08-12 | $7.00M 10-Q · filed 2011-08-12 | ||
| 2009-12-31 | $13.60M 10-K · filed 2012-03-27 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| NovoCure Ltd (NVCR) | $1.886B | -11.87 | |
| Inspire Medical Systems, Inc. (INSP) | United States | $1.990B | 9.55 |
| KESTRA MEDICAL TECHNOLOGIES, LTD. (KMTS) | United States | $1.535B | -9.02 |
| Alphatec Holdings, Inc. (ATEC) | United States | $1.531B | -12.14 |
| UFP TECHNOLOGIES INC (UFPT) | United States | $2.308B | 28.37 |
| INTEGRA LIFESCIENCES HOLDINGS CORP (IART) | United States | $1.234B | -193.02 |
| ARTIVION, INC. (AORT) | United States | $1.123B | -345.09 |
| IRADIMED CORP (IRMD) | United States | $1.089B | 52.92 |
| TANDEM DIABETES CARE INC (TNDM) | United States | $1.059B | -16.57 |
| PROCEPT BioRobotics Corp (PRCT) | United States | $1.001B | -11.77 |